FULC - Fulcrum Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 3-7.60%
52 Week High 322.96
52 Week Low 34.37
50-Day Moving Average 314.06
200-Day Moving Average 312.43

Share Statistics

Avg Vol (3 month) 3100.31k
Avg Vol (10 day) 382.73k
Shares Outstanding 523.34M
Float 8.38M
% Held by Insiders 116.33%
% Held by Institutions 164.64%
Shares Short (Mar 12, 2020) 4267.04k
Short Ratio (Mar 12, 2020) 43.4
Short % of Float (Mar 12, 2020) 43.17%
Short % of Shares Outstanding (Mar 12, 2020) 41.14%
Shares Short (prior month Feb 13, 2020) 4179.53k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Dec 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-53.65%
Return on Equity (ttm)-101.35%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -82.16M
Net Income Avi to Common (ttm)-89.81M
Diluted EPS (ttm)-14.92
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)96.71M
Total Cash Per Share (mrq)4.26
Total Debt (mrq)71k
Total Debt/Equity (mrq)0.08
Current Ratio (mrq)8.24
Book Value Per Share (mrq)4.53

Cash Flow Statement

Operating Cash Flow (ttm)-39.48M
Levered Free Cash Flow (ttm)-41.47M